- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05668845
Paragastric Autonomic Neural Blockade as Part of Combined Anesthesia.
May 7, 2023 updated by: Universidad Simón Bolívar
Paragastric Autonomic Neural Blockade as Part of Combined Anesthesia. Impact on Anesthetic Agents Consumption: A Randomized Clinical Trial Protocol
To evaluate the effect of early autonomic blockade on the consumption of remifentanil and halogenated anesthesia in the intraoperative period during laparoscopic sleeve gastrectomy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Balanced general anesthesia, even if combined with local anesthesia or parietal blocks such as transversus abdominis plane (TAP), subcostal, or pararectal blocks, is insufficient to block the autonomic impulses released during most intra-abdominal visceral surgeries, especially in laparoscopic sleeve gastrectomy (LSG).
These impulses are, in part, responsible for the hemodynamic changes observed during different phases of LSG and the subsequent visceral pain and associated symptoms, such as nausea and vomiting, observed in a substantial number of patients in the immediate postoperative period after LSG and other minimally invasive procedures.
Visceral pain substantially impacts patients' quality of life, recovery time, nursing time allocation, and resultant risk of opioid abuse.
Nausea, food intolerance, and pain are responsible for most readmissions after LSG and other bariatric procedures.
Many of these patients have associated severe respiratory impairments and other comorbidities.
They often need increased amounts of halogenated anesthetics, opioid analgesics, antiemetics, and other anesthetic modalities such as epidural anesthesia.
A recent randomized clinical trial (RCT) demonstrated that a novel approach, namely paragastric autonomic neural blockade (PG-ANB), is safe and effective in addressing visceral pain while reducing the need for analgesics, including opioids and the decreasing nausea and vomiting in the first 24 hours after a laparoscopic sleeve gastrectomy.
In an observational series, we found that by performing PG-ANB as the first step in LSG, the need for morphine-equivalent doses and halogenated anesthetics diminished, and hemodynamic stability increased while maintaining the previously reported reduction of postoperative visceral pain and associated symptoms.
Similarly, when implementing a variation of the autonomic blockade targeting proper pathways as an early step in cholecystectomy, the same beneficial effects were observed in affected patients.
Study Type
Interventional
Enrollment (Actual)
79
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Atlantico
-
Barranquilla, Atlantico, Colombia, 080020
- clinicas Portoazul e Iberoamerica
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
-all adult patients scheduled for LSG at each participating institution.
Exclusion Criteria
- the inability to perform a PG-ANB because of anatomical difficulties
- the need for revisional surgery
- the need for concomitant hiatal hernia repair or other surgical procedures
- conversion to open surgical procedures
- allergies to local anesthetics or medication described in the anesthesia protocol
- intraoperative complications (e.g., visceral or vascular perforations)
- anesthesia-related complications requiring admission to intensive care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PG-ANB performed at the outset of LSG
PG-ANB is performed early in the procedure as a first step before starting the sleeve gastrectomy.
|
The paragastric lesser omentum neural block is performed with a 25-gauge needle attached to a venous catheter extension introduced through the left 12-mm port.
The needle is capped during its introduction, and the cap is removed inside the abdomen using a grasper and kept under direct vision.
Infiltration of 20 mL of non-diluted 0.5% bupivacaine is performed at six levels with careful aspiration preceding fluid infiltration.
Four areas are adjacent to the vagus nerves and branches, and two are in the vicinity of the common hepatic and left gastric arteries.
This is performed at the outset of the LSG.
|
|
Active Comparator: PG-ANB performed at the end of LSG
PG-ANB is performed at the end of the sleeve gastrectomy
|
The paragastric lesser omentum neural block is performed with a 25-gauge needle attached to a venous catheter extension introduced through the left 12-mm port.
The needle is capped during its introduction, and the cap is removed inside the abdomen using a grasper and kept under direct vision.
Infiltration of 20 mL of non-diluted 0.5% bupivacaine is performed at six levels with careful aspiration preceding fluid infiltration.
Four areas are adjacent to the vagus nerves and branches, and two are in the vicinity of the common hepatic and left gastric arteries.
This is performed at the end of the LSG>
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intraoperative Remifentanil consumption
Time Frame: duration of the anesthesia
|
The amount of remifentanil administered will be calculated based on the amount of the consumed mix and reported as total mcg and mcg/kg/min.
|
duration of the anesthesia
|
|
Intraoperative consumption of the halogenated agent (sevoflurane)
Time Frame: duration of the anesthesia
|
The anesthetic machine will determine the administered amount of sevoflurane (Dräger Primus) which will be reported in ml/min.
|
duration of the anesthesia
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
recovery from anesthesia measured by the Modified Aldrete Scale
Time Frame: one hour after surgery
|
The Modified Aldrete scale from 0 to 15 (a higher score correlates with better recovery from anesthesia) will be assessed and recorded 15 minutes and 1 hour after surgery.
|
one hour after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Rafael Pantoja, MD, Universidad Simón Bolívar
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2023
Primary Completion (Actual)
April 15, 2023
Study Completion (Actual)
May 1, 2023
Study Registration Dates
First Submitted
November 26, 2022
First Submitted That Met QC Criteria
December 24, 2022
First Posted (Actual)
December 30, 2022
Study Record Updates
Last Update Posted (Actual)
May 9, 2023
Last Update Submitted That Met QC Criteria
May 7, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PRO-CEI-USB-CE-0394-01
- PRO-CEI-USB-CE-0394-02 (Unisimon)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia Morbidity
-
University of PecsCompleted
-
Cairo UniversityRecruiting
-
Universitätsklinikum Hamburg-EppendorfRecruitingAnesthesia Morbidity | Neurological Morbidity | Surgical ComplicationGermany
-
University of Maryland, BaltimoreAnesthesia Patient Safety FoundationCompleted
-
Cairo UniversityCompletedAnesthesia MorbidityEgypt
-
Koç UniversityCompletedRegional Anesthesia MorbidityTurkey (Türkiye)
-
Sivas State HospitalCompletedRegional Anesthesia MorbidityTurkey
-
Zulekha HospitalsCompletedRegional Anesthesia MorbidityEgypt
-
Senthil G. KrishnaTerminated
-
Bogomolets National Medical UniversityActive, not recruiting
Clinical Trials on PG-ANB performed at the outset of LSG
-
University Hospital, GrenobleRecruiting
-
Université de MontréalCanadian Institutes of Health Research (CIHR)Completed
-
Qassim UniversityRecruiting
-
The Geneva FoundationUniformed Services University of the Health Sciences; Congressionally Directed...Not yet recruitingTraumatic Brain Injury | Intracranial Hemorrhages | Combat Casualty Care | Point of CareUnited States
-
University of CopenhagenDepartment of Biomedical Sciences; XLab, Center of Healthy AgingCompletedType 2 Diabetes and ExerciseDenmark
-
Centre Francois BaclesseUniversity Hospital, CaenTerminatedRelation Between Safety Endpoints and Everolimus Trough Blood Level in Advanced Renal Cell CarcinomaRenal Cell CarcinomaFrance
-
Ataturk UniversityCompletedAnesthesia, Local | Cesarean Section Complications | HypotensionTurkey
-
Nantes University HospitalCompletedPatients Receiving Animal-derived Bioprosthetic Heart ValvesFrance, Canada, Italy, Spain
-
University of DerbyRecruitingOld Age; Debility | Stability | Balance; DistortedUnited Kingdom
-
University of LeipzigActive, not recruiting